Signed in as:
filler@godaddy.com
2025 Headlines
2025 DEA National Drug Threat Report (May 2025)U.S. Overdose Deaths 27% Decrease from 2023 to 2024 (CDC, May 2025)Patient Care with a Touch of Disney (Drug Topics, April 2025)OTC Pain Medications (Drug Topics, April 2025)APhA 2025 Takeaways (Drug Topics, April 2025)17-Year-Old Creating New Acetaminophen (April 2025)Psychedelics & Clinical Trials (Drug Topics Interview, March 2025)Opioid Best Practices (Med Central March 2025)Buprenorphine Injection Label Update (Feb 2025)New Year, New DEA Logo (Jan 2025)
2024 Headlines
FDA Opioid REMS Mail-Back Envelopes Requirement (Nov 2024)GLP-1's & OUD/AUD (October 2024)Naloxone Med Central Article (August 2024)Supercharged Naloxone Study (August 2024)Nalmefene Auto-Injector FDA Approved (August 2024)BPS Pain Management Council (June 2024)U.S. Supreme Court Rejects Sackler Settlement (June 2024)55% of Patients with OUD Receive Treatment (CDC MMWR June 2024)6-Methyl Nicotine (May 2024)Naloxone 20Ways Article (May 2024)DEA Rescheduling Cannabis as CS-3 (April 2024)Gabapentin Utilization (Pharmacy Today, April 2024)Controlled Substance Red Flags (U.S. Pharmacist, April 2024)Controlled Substance Red Flags (Drug Topics, March 2024)Buprenorphine Chronic Pain Article (JMH March 2024)Naloxone Nasal Spray 8mg vs 4mg (Feb 2024)HHS Methadone Updates (Feb 2024)CBD for Pain --> Ineffective (Oct '23 Article)
2023 Headlines
Naloxone 3mg NS Available (Dec 2023)Gas Station Heroin (December 2023)Project Mushroom (November 2023)FDA Approves OTC Fentanyl Test Strips (Oct 2023)DEA TeleMedicine Extended Through 2024 (Oct 2023)"Fentanyl Fighter" on Rx Shelves (Oct 2023)OTC Naloxone Nasal Spray 3mg FDA-Approved (July 2023)DEA C-2 Electronic Rx Transfers (July 2023)Bath Salt: DMP (July 2023)Rx Opioid Shortage (July 2023)Xylazine '19 to '22 OD Deaths (June 2023)Bup Week/Month Inj FDA Approval (May 23, 2023)Nalmefene FDA Approval (May 22, 2023)GLP-1 Agonists for Addiction? (May 2023)Sulfa's as Street Drugs (May 2023)Cannabis Based Medicine in Pain (April 2023)Phenylbutazone (March 2023)OTC Naloxone (March 2023)SAMHSA DEA Reg SUD Training Recs (March 2023)Gabapentin & Opioids (Pharmacy Today, March 2023)WV OTC Pain Meds Project (JPPCP, March 2023)MAT & MATE Acts (DEA X-Waiver Elimination, Jan 2023)Academia in the Opioid Epidemic (AACP, Jan 2023)
Google AdSense
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
